These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 12392496)
1. Fatty acids are important for the Frank-Starling mechanism and Gregg effect but not for catecholamine response in isolated rat hearts. Pagliaro P; Chiribiri A; Gattullo D; Penna C; Rastaldo R; Recchia FA Acta Physiol Scand; 2002 Nov; 176(3):167-76. PubMed ID: 12392496 [TBL] [Abstract][Full Text] [Related]
2. Role of the fuel utilized by tissues on coronary vessel response to physical stimuli in isolated rat hearts. Pagliaro P; Gattullo D Physiol Res; 2004; 53(1):27-34. PubMed ID: 14984311 [TBL] [Abstract][Full Text] [Related]
3. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion. Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401 [TBL] [Abstract][Full Text] [Related]
4. Acylcarnitine accumulation does not correlate with reperfusion recovery in palmitate-perfused rat hearts. Madden MC; Wołkowicz PE; Pohost GM; McMillin JB; Pike MM Am J Physiol; 1995 Jun; 268(6 Pt 2):H2505-12. PubMed ID: 7611501 [TBL] [Abstract][Full Text] [Related]
5. Demand-induced ischemia in volume expanded isolated rat heart; the effect of dichloroacetate and trimetazidine. Skierczynska A; Beresewicz A J Physiol Pharmacol; 2010 Apr; 61(2):153-62. PubMed ID: 20436215 [TBL] [Abstract][Full Text] [Related]
6. Coronary hyperemia and cardiac hypertrophy following inhibition of fatty acid oxidation. Evidence of a regulatory role for cytosolic phosphorylation potential. Higgins AJ; Faccini JM; Greaves P Adv Myocardiol; 1985; 6():329-38. PubMed ID: 3158046 [TBL] [Abstract][Full Text] [Related]
7. The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts. Onay-Besikci A; Guner S; Arioglu E; Ozakca I; Ozcelikay AT; Altan VM Can J Physiol Pharmacol; 2007 May; 85(5):527-35. PubMed ID: 17632588 [TBL] [Abstract][Full Text] [Related]
8. Effect of chronic CPT-1 inhibition on myocardial ischemia-reperfusion injury (I/R) in a model of diet-induced obesity. Maarman G; Marais E; Lochner A; du Toit EF Cardiovasc Drugs Ther; 2012 Jun; 26(3):205-16. PubMed ID: 22407171 [TBL] [Abstract][Full Text] [Related]
9. Effects of the fatty acid blocking agents, oxfenicine and 4-bromocrotonic acid, on performance in aerobic and ischemic myocardium. Molaparast-Saless F; Liedtke AJ; Nellis SH J Mol Cell Cardiol; 1987 May; 19(5):509-20. PubMed ID: 3625784 [TBL] [Abstract][Full Text] [Related]
10. Carnitine palmitoyl transferase-I inhibition is not associated with cardiac hypertrophy in rats fed a high-fat diet. Okere IC; Chandler MP; McElfresh TA; Rennison JH; Kung TA; Hoit BD; Ernsberger P; Young ME; Stanley WC Clin Exp Pharmacol Physiol; 2007; 34(1-2):113-9. PubMed ID: 17201745 [TBL] [Abstract][Full Text] [Related]
11. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation. Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298 [TBL] [Abstract][Full Text] [Related]
12. Acute effect of antidiabetic 1,4-dihydropyridine compound cerebrocrast on cardiac function and glucose metabolism in the isolated, perfused normal rat heart. Briede J; Stivrina M; Vigante B; Stoldere D; Duburs G Cell Biochem Funct; 2008; 26(2):238-45. PubMed ID: 17990288 [TBL] [Abstract][Full Text] [Related]
13. Effect of perhexiline and oxfenicine on myocardial function and metabolism during low-flow ischemia/reperfusion in the isolated rat heart. Kennedy JA; Kiosoglous AJ; Murphy GA; Pelle MA; Horowitz JD J Cardiovasc Pharmacol; 2000 Dec; 36(6):794-801. PubMed ID: 11117381 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP. Ebihara Y; Karmazyn M Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523 [TBL] [Abstract][Full Text] [Related]
15. Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure. Lionetti V; Linke A; Chandler MP; Young ME; Penn MS; Gupte S; d'Agostino C; Hintze TH; Stanley WC; Recchia FA Cardiovasc Res; 2005 Jun; 66(3):454-61. PubMed ID: 15914110 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of carnitine-acyl transferase I by oxfenicine studied in vivo with [11C]-labeled fatty acids. Angsten G; Valind S; Takalo R; Neu H; Meurling S; Långström B Nucl Med Biol; 2005 Jul; 32(5):495-503. PubMed ID: 15982580 [TBL] [Abstract][Full Text] [Related]
17. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload. Doenst T; Pytel G; Schrepper A; Amorim P; Färber G; Shingu Y; Mohr FW; Schwarzer M Cardiovasc Res; 2010 Jun; 86(3):461-70. PubMed ID: 20035032 [TBL] [Abstract][Full Text] [Related]
18. Effect of gender and fatty acids on ischemic recovery of contractile and pump function in the rat heart. Broderick TL; Glick B Gend Med; 2004 Dec; 1(2):86-99. PubMed ID: 16115587 [TBL] [Abstract][Full Text] [Related]
19. Influence of metabolic substrate on rat heart function and metabolism at different coronary flows. Burkhoff D; Weiss RG; Schulman SP; Kalil-Filho R; Wannenburg T; Gerstenblith G Am J Physiol; 1991 Sep; 261(3 Pt 2):H741-50. PubMed ID: 1887921 [TBL] [Abstract][Full Text] [Related]
20. Load-induced changes in vivo alter substrate fluxes and insulin responsiveness of rat heart in vitro. Doenst T; Goodwin GW; Cedars AM; Wang M; Stepkowski S; Taegtmeyer H Metabolism; 2001 Sep; 50(9):1083-90. PubMed ID: 11555843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]